Gomisin M2(CAS: 82425-45-4)

Gomisin M2 (CAS: 82425-45-4) falls under the regulatory frameworks such as REACH in the European Union, which requires registration, evaluation, authorization, and restriction of chemicals. It also adheres to GHS (Globally Harmonized System of Classification and Labeling of Chemicals) for classification and labeling. FDA and EPA guidelines are applicable for its use in food and environmental contexts.

Gomisin M2 (CAS: 82425-45-4) can be synthesized using various alternatives such as isomers or analogs like Gomisin M1 or other lignan derivatives. Common substitute reagents include boron trifluoride and sodium borohydride in different reaction conditions, providing flexibility in synthetic pathways.

The market for Gomisin M2 (CAS: 82425-45-4) is growing due to its potential in drug discovery and natural product chemistry research. Recent trends indicate an increase in research focused on its anti-inflammatory and anti-cancer properties. Market demand is also influenced by growing interest in traditional Chinese medicine and functional food ingredients.

Waste containing Gomisin M2 (CAS: 82425-45-4) should be collected in appropriate containers and disposed of via incineration or professional waste disposal services. Proper environmental precautions include ensuring no contamination of soil or water sources. Safe handling and disposal practices must comply with local and international environmental regulations to prevent pollution.